Physician profile
Paul Megehee
NPI 1275511784
$891.15
in general payments reported to CMS, 2019-2025
17 companies · $52.04 in 2025
The $52.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $83.49 · 2021: $244 · 2022: $157 · 2023: $134 · 2024: $104 · 2025: $52.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $154.38 | 2022-2024 | V-Loc 180 |
| Abbvie INC. | $119.41 | 2019-2022 | |
| Pfizer INC. | $100.16 | 2019-2025 | |
| Daiichi Sankyo INC. | $97.72 | 2020-2021 | |
| Hologic Sales and Service, LLC | $92.93 | 2019-2023 | Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $67.90 | 2023-2025 | |
| Aspira Women'S Health INC | $43.50 | 2021 | |
| Mylan Pharmaceuticals INC. | $28.78 | 2021-2022 | |
| Astellas Pharma US INC | $28.77 | 2024 | Veozah |
| Shield Therapeutics INC | $24.66 | 2023 | Accrufer |
| Amgen INC. | $22.85 | 2019 | |
| Organon LLC | $22.35 | 2022 | |
| Amag Pharmaceuticals, INC. | $19.94 | 2019 | |
| Exeltis, USA INC. | $18.72 | 2023 | Slynd |
| Scynexis, INC. | $17.97 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monaghan Medical Corporation | $15.83 | 2023 | Aerobika |
| Sumitomo Pharma America, INC. | $15.28 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Megehee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.